Galmed Pharmaceuticals Ltd (NASDAQ:GLMD)

9.73
Delayed Data
As of Jul 02
 -0.52 / -5.07%
Today’s Change
4.58
Today|||52-Week Range
13.50
+67.76%
Year-to-Date
No recent news for Galmed Pharmaceuticals Ltd.

Today’s Trading

Previous close10.25
Today’s open10.10
Day’s range9.33 - 10.10
Volume36,957
Average volume (3 months)46,317
Market cap$108.0M
Dividend yield--
Data as of 3:59pm ET, 07/02/2015

Growth & Valuation

Earnings growth (last year)-125.51%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratio--
Price/Sales--
Price/Book3.44

Competitors

 Today’s
change
Today’s
% change
RNNRexahn Pharmaceutica...-0.01-0.98%
REPHRecro Pharma Inc+0.79+6.11%
AKAOAchaogen Inc-0.21-3.47%
AXNAoxing Pharmaceutica...+0.01+0.63%
Data as of 4:02pm ET, 07/02/2015

Financials

Next reporting dateJuly 24, 2015
EPS forecast (this quarter)-$0.25
Annual revenue (last year)$0.00
Annual profit (last year)-$9.1M
Net profit margin--

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Allen Baharaff
Chief Financial Officer
Josh Blacher
Corporate headquarters
Tel Aviv, Tel Aviv

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers